ENTX: Entera Bio, Ltd. (the "Issuer") insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-04 | New 13G stake | Longitude Capital Partners V, LLC | 4.60% | SEC | |
| 2026-08-04 | New 13G stake | Seven Fleet Horizon Master Fund LP | 4.10% | SEC | |
| 2026-08-04 | New 13D stake | BIOTECHNOLOGY VALUE FUND L P | 9.99% | SEC | |
| 2026-08-04 | New 13G stake | TCG Crossover GP III, LLC | 7.10% | SEC | |
| 2026-08-04 | New 13G stake | Vivo Opportunity Fund Holdings, L.P. | 6.90% | SEC |
Institutional ownership (Q2 2026)
27 institutions reported holding $18.77M of Entera Bio, Ltd. (the "Issuer") on Form 13F (26 the quarter before). 7 opened a new position and 6 sold out. Shares held by institutions: +36%.
| Largest holders | Shares | Value |
|---|---|---|
| Knoll Capital Management, LLC | 5,881,879 | $10.41M |
| BVF INC/IL | 2,425,000 | $4.29M |
| Siren, L.L.C. | 736,457 | $1.30M |
| RENAISSANCE TECHNOLOGIES LLC | 368,847 | $653K |
| Parkman Healthcare Partners LLC | 274,497 | $486K |
| PNC Financial Services Group, Inc. | 273,031 | $483K |
| Seven Fleet Capital Management LP | 191,354 | $339K |
| HighTower Advisors, LLC | 74,573 | $133K |
| Schonfeld Strategic Advisors LLC | 58,871 | $104K |
| TWO SIGMA SECURITIES, LLC | 48,593 | $86K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.